Ifp Advisors, Inc Aquestive Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.63 - $1.73 $315 - $865	-500 Reduced 7.14%	6,500 $104,000
Q2 2022 Sep 06, 2022	BUY	$0.64 - $2.57 $4,480 - $17,990	7,000 New	7,000 $112,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $4,480 - $17,990	-7,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.28 - $4.26 $15,959 - $29,820	7,000 New	7,000 $18,000

121

46.7M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $163M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.